Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Tavaborole Solution in Onychomycosis
NCT00679523Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tavaborole in onychomycosis, sponsored by Pfizer. Started Nov 2005; status: completed.
02
Drugs
tavaborole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT00679523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679523.